NCT Number: NCT02157727
Cost-effectiveness of Tele-expertise for Premature Infants for Retinopathy
The purpose of this study is to determine whether telemedicine would be as effective as having a pediatrics ophthalmologist on site for screening examination of retinopathy in premature infants and would be cost-effective.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
Service de réanimation néonatale. Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Born before 32 WA or having a birth weight under 1500g
Exclusion criteria
- Brain malformations
Treatment and study plan
Primary outcomes
-
Proportion of premature infants being screened for retinopathy following recommendations
Time frame: 4 weeks in average
Proportion of premature infants being screened for retinopathy following recommendations (between 31 and 32 weeks of amenorrhea (WA) for infants born before 28 WA and during the fourth week of life for infants born after 28 WA)
Secondary outcomes
-
Delay before the first screening of retinopathy
Time frame: 4 weeks in average
For infants born at or after 28WA
-
Cost of telemedicine
Time frame: 6 months after enrollment of the first patient
Sponsors and collaborators
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Other
Collaborators
- Agence Regionale de Sante d'Ile de France
Registry information
Official study title
Effectiveness and Cost-effectiveness of Tele-expertise for the Screening Examination of Premature Infants for Retinopathy of Prematurity
Acronym: Dite-ROP
Important dates
- Study start
- 2014
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Jun 6, 2014
- Registry last updated
- Oct 14, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
NCT05387941
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Lund, Skåne County, Sweden
View Trial DetailsStudy of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants
NCT02820662
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Dijon, France
View Trial DetailsAutomated Screening Device to Detect MTMROP
NCT06517836
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Portland, Oregon, United States
View Trial DetailsIron and Retinopathy of Prematurity (ROP)
NCT05133999
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Paris, France
View Trial Details